Monitoring Ozempic use in sport: the miracle drug that surely swerves the doping code?
The World Anti-Doping Agency has added the active ingredient semaglutide to its watch-list for 2025
Wegovy
Insurers will not cover obesity drugs that will cost users €2,500-plus a year
Patients looking to access Eli Lilly’s Mounjaro from next week will have to pay privately
Electricity network upgrades likely to see user bills rise
Seen & heard: Developers summoned; Xerotech on the brink; Glencore eyes Pallas Green sale; CRH invests in 3D; Mounjaro arrives; and O’Hara brewery talks
Lilly’s Zepbound tops Novo Nordisk’s Wegovy for weight loss in head-to-head trial
Companies competing for leadership in fast-growing market where supply continues to be an issue
Sharp increase in number of illegal weight loss drugs seized
HPRA warns of risks of illegal, counterfeit versions of drugs such as Ozempic and Wegovy, saying they pose ‘significant risk’
Obesity drugmaker Novo Nordisk misses profit forecast
Danish company employs about 450 people in Ireland
Novo Nordisk drops Dublin factory plan
Seen & Heard: Inheritance tax reduction, Press Up stake and Spar sale
Large increase in number of fake weight-loss drugs seized by watchdog in 2024
Officials warned consumers of risks from falsified versions of Ozempic and Wegovy
Ozempic and Wegovy maker Novo Nordisk set to build large manufacturing facility in Dublin
News of new factory comes after Danish group announced in December the purchase of drug manufacturing plant in Athlone in order to keep up with demand for weight-loss drugs
Ozempic maker Novo Nordisk buys Irish drug manufacturing plant in €85m deal
Danish weight loss and diabetes specialist is looking to develop a tablet form of its blockbuster obesity treatments
Weight-loss drugs hurt snack company shares
Concerns about weight-loss drugs hurting sales are ‘overblown’ say Citi analysts but investors are worried
The Truth About the ‘Skinny’ Jab: Are weight-loss injections a magic wand or potential health disaster?
Television: Presenter Anna Richardson explores how drugs like Ozempic and Wegovy work and the potential side effects
Obesity drugs make Novo Nordisk Europe’s biggest company
Company boosted by trial results showing weight loss drug also cuts risk of heart attack by 20%
Glanbia boss Siobhán Talbot leaves company in rude health
Food company boss has successfully steered group into high-margin nutritional space
Novo Nordisk says obesity pill leads to 15% weight loss
Danish drugmaker pushing for US and EU approval but has struggled to meet demand for its Ozempic and Wegovy drugs
Ireland on the cusp of obesity treatment revolution but high cost of drugs causing disquiet
Medications offer hope to patients with severe weight problems but will also be demanded by many for aesthetic reasons
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Stardust
Inquests into the nightclub fire that led to the deaths of 48 people
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices